There’s a simple screening for people with sickle cell disease that can prevent strokes. There’s also medication for significant sickle cell disease effects. So why are less than half of patients getting screened—and why have some patients never even heard of the medication? Dr. Julie Kanter of the University of Alabama-Birmingham and its Adult Sickle Cell Clinic explores sickle cell disease research’s chronic state of underfunding.
Show More...